Background and objectives: Off-pump coronary artery bypass grafting (CABG) has been advocated to cause less inflammation, morbidity, and mortality than the more traditional on-pump technique. This meta-analysis compares these two surgical techniques with respect to causing acute kidney injury (AKI).
F irst introduced in the 1960s (1-3), coronary artery bypass grafting (CABG) remains the standard of care for symptomatic patients with three-vessel or left main coronary artery disease (4, 5) . For the past 30 years, CABG has been performed primarily with the use of an extracorporeal cardiopulmonary bypass (CPB) machine (on-pump) requiring cannulation of the heart and aorta, crossclamping of the ascending aorta, and the induction of cardioplegic arrest. However, in the 1990s, interest emerged in performing off-pump CABG (6, 7) with the hope of reducing postoperative complications associated with the use of CPB, including the generalized systemic inflammatory response (8) and acute organ dysfunction such as cerebral dysfunction (9) , myocardial depression (10) , and prolonged mechanical ventilation (11) .
Acute kidney injury (AKI) is a serious complication of on-pump CABG, ranging from small postoperative increases in serum creatinine observed in 5% to 20% of patients (12, 13) to severe forms requiring dialysis developing in 1% of patients (14, 15) . Whether defined by various serum creatinine increments or dialysis requirement, AKI has been linked to excessive in-hospital morbidity and mortality (12, 14) and increased resource consumption (16, 17) . With an estimated 176,000 cardiac bypass procedures performed in 2007 (18) , preventing AKI postoperatively is an important goal.
Previously published studies comparing the effect of off-pump versus on-pump CABG on kidney end points have yielded conflicting results. Although six meta-analyses have examined this question, results were inconclusive (19, 20) or the data synthesis included studies of various designs with a mixture of randomized controlled trials (RCTs) and observational studies (21) (22) (23) (24) . To shed further light on this question, we conducted a comprehensive meta-analysis restricted to all RCTs published to date, comparing the effect of off-pump versus on-pump CABG on development of AKI including dialysis requirement.
Materials and Methods

Eligibility Criteria
We included all RCTs that examined postoperative primary or secondary kidney end points (as defined below) in adults undergoing off-pump versus on-pump CABG surgery. We excluded duplicate publications. If authors published more than one manuscript on the same study, data from the most inclusive report were used.
Search Strategy
We searched MEDLINE (1966 to February 2010) using the following MeSH database search terms: "Coronary Artery Bypass," "Coronary Artery Bypass, Off-Pump," "Cardiopulmonary Bypass," "Heart Bypass, Left," or "Extracorporeal Circulation," and "Heart, Artificial." The search strategy was limited to human RCTs with no language restrictions. We also searched ClinicalTrials.gov for completed trials using similar search terms; reviewed abstracts from the annual scientific 
Study Selection
Two independent reviewers (S.A. and V.F.S.) screened the titles and abstracts of all electronic citations. The full-text articles were retrieved for comprehensive review and rescreened. A third reviewer (A.H.P.) screened the abstracts from the annual scientific meetings.
Outcome Measures
The primary outcome was AKI, as defined in individual trials. We focused on AKI in general and dialysis requirement specifically. For the purpose of the meta-analysis, dialysis was defined as the need for hemodialysis or continuous renal replacement therapy (e.g., hemofiltration). The secondary outcome was all-cause mortality and was evaluated only among trials that reported kidney end points.
Data Abstraction
Two reviewers (S.A. and V.F.S.) independently extracted in duplicate the following data from full-text articles: country of origin, year of publication, period of study, study design, population setting (first versus redo CABG), surgery electivity, patient summary characteristics (including sex, mean age, prevalence of hypertension, and diabetes mellitus), mean aortic cross-clamp and CPB time, definition of AKI, and duration of follow-up. Disagreements were resolved through consensus. Eleven authors were contacted by e-mail (up to three attempts per author) for additional information, including confirmation that there were no duplicate data and clarification of the AKI definition used in trials (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Five authors provided additional information (25, 29, 30, 32, 33) .
Quality Assessment
One reviewer (V.F.S.) assessed the quality of the trials using the Jadad scale, (36), which is based on the adequacy of randomization, blinding, and attrition. This 0 to 5 scale, with a score of 5 corresponding to "best" quality, was used as a surrogate for overall quality assessment (Appendix 1).
Statistical Analyses
We performed meta-analyses of the odds ratio (OR) for AKI, dialysis requirement, and death in patients undergoing off-pump CABG relative to those undergoing on-pump CABG. Because of the low number of events in most studies (often zero in one study group), we used the Peto fixed-effect model for our primary analysis (37, 38) . As a sensitivity analysis, we also performed a random-effects model meta-analysis (39) . For both methods, the studies with no events in both groups were excluded from the meta-analyses. For graphical purposes, we calculated the OR for studies with no events in either group by adding 0.5 to the numbers of events and nonevents and displayed the resulting OR in the forest plots. We calculated the I 2 and the 2 P value to assess for heterogeneity among studies. To evaluate the heterogeneity, we performed subgroup analyses using the Peto fixed-effect model on the basis of a priori selected characteristics including mean age (Ͻ65 versus Ն65 years), percentage with diabetes mellitus (Ͻ25 versus Ն25%), sample size (less than versus median or greater), AKI incidence rate and mortality rate in the on-pump CABG group (less than versus median or greater), surgery setting (elective versus urgent/elective), AKI definition (biochemical parameter/urine output versus dialysis requirement), percentage with hypertension (less than versus median or greater), and study quality (defined by the Jadad score). The t test was used to compare subgroups. The summary control rates (event rates in the on-pump CABG groups) were determined with random-effects model meta-analysis, including studies with no events. The meta-analyses were performed using MetaAnalyst beta version 3.1 (Tufts University, Boston, MA) (40) and the metan command (version 9) in Stata version 11 (41) .
Results
Study Characteristics
A total of 6256 potentially relevant citations were identified and screened, of which 5232 originated from MEDLINE; 224 articles were retrieved for detailed evaluation, of which 22 fulfilled eligibility criteria ( Figure 1 ) (25) (26) (27) (28) (29) (30) (32) (33) (34) (35) (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) .
Characteristics of the individual trials are displayed in Table 1 . The trials spanned more than 10 years and varied in sample size from 20 to 2203 patients. All trials had more men, ranging from 52% to 99%, with a range of mean ages of 48 to 76 years. When reported, mean preoperative serum creatinine ranged from 1.0 to 1.5 mg/dl. By design, one trial restricted enrollment to patients with pre-existing chronic kidney disease (52) and another study was restricted to patients undergoing urgent CABG (32) . All 22 studies reported on the incidence of AKI, with seven studies defining AKI exclusively as the need for dialysis (25,26,33,47,49 -51) . Six studies did not describe the criteria used to define AKI (27, 34, 35, 42, 46, 48) . The remaining nine studies defined AKI using variable absolute or relative increases in serum creatinine, decreases in GFR, decreases in urine output, or need for dialysis (Table 2) (28 -30,32,43-45,  52,53) . Death was ascertained in-hospital in nine trials (25, (27) (28) (29) 32, 34, 46, 48, 51) , at 30 days in nine trials (25, 26, 30, 33, 35, 44, 45, 47, 53) , and at 60 days in one trial (42) . The duration of follow-up was not documented in the three remaining studies (43, 50, 52) .
Study Quality
The criteria used to assess study quality are listed in Appendix 1 with overall poor (arbitrarily defined as 0 to 1 on the Jadad scale) to fair (2,3) Jadad quality scores. Because no RCT was double-blinded because of the nature of the intervention, no study could be rated as good (4, 5) by the Jadad quality score. In brief, randomization was adequate in 12 (26,28,30,32-35, 45,47,51-53) of the 14 trials that documented the procedure (26,28 -30,32-35,44,45,47,51-53) , but there were attrition and crossover rates as high as 13% and 11%, respectively. Only three studies reported on allocation concealment (29, 30, 35) . Among the 15 trials that provided optimal documentation of their analysis (25,26,28,33,34,43-49,51-53) , 11 used an intent-totreat analysis (25, 26, 28, 33, 34, 43, 45, 47, 49, 51, 53) .
Data Synthesis and Analysis Effect of Off-Pump CABG on AKI
All 22 RCTs, with a total of 4819 analyzable patients (Figure 2 ), reported AKI rates. The overall weighted incidence of AKI in the on-pump CABG group was 4.0% (95% confidence interval [CI] 1.8%, 8.5%; range 0%, 62%). By meta-analysis, off-pump CABG was associated with a 40% lower odds of postoperative AKI (OR 0.60; 95% CI 0.43, 0.84; P ϭ 0.003). However, nine studies had no patients with AKI in either group and thus did not contribute to the meta-analysis. Although the trials differed considerably in their size and quality score, the test for heterogeneity of effects was not significant (I 2 ϭ 0%; P ϭ 0.56).
Effect of Off-Pump CABG on Dialysis Requirement
The analysis included 20 RCTs, with a total of 4626 analyzable patients (Figure 3) . However, nine studies had no patients who required dialysis in either group and thus did not contribute to the meta-analysis. The overall weighted incidence of dialysis requirement in the on-pump CABG group was 2.4% (95% CI 1.6%, 3.7%; range 0%, 7%). By meta-analysis, off-pump CABG was associated with a nonstatistically significant 33% lower odds of dialysis requirement (OR 0.67; 95% CI 0.40, 1.12; P ϭ 0.12).
Effect of Off-Pump CABG on Mortality
This analysis was restricted to the 21 RCTs that reported both AKI and mortality results. They included a total of 4759 analyzable patients (Figure 4) . However, nine studies had no deaths in either group and thus did not contribute to the meta-analysis. The overall weighted mortality rate in the onpump CABG group was 2.6% (95% CI, 1.6%, 4.0%; range 0%, 8%). By meta-analysis, off-pump CABG was not associated with a significant reduction in mortality compared with onpump CABG (OR 0.79; 95% CI 0.50, 1.25; P ϭ 0.31).
Subgroup and Sensitivity Analyses
Despite the absence of significant heterogeneity among the trials, to explore the robustness of our findings in the Peto fixed-effects model, we repeated the meta-analyses using random-effects models and performed several subgroup analyses. As shown in Figures 2 through 4 , the random-effects models displayed similar effect estimates. The subgroup analyses are displayed in Figure 5 . In brief, pooled point estimates for AKI in the off-pump CABG group had larger effects among studies that had a lower mean age (Ͻ65 versus Ն65 years), were restricted to elective CABG surgery, had a lower Jadad quality score (0 to 1 versus 2 to 3), and had a higher prevalence of hypertension (Ն66% versus Ͻ66%). Subgroup analyses among studies that used a more liberal definition of AKI (entailing a mixture of biochemical parameter/urine output/dialysis requirement) did not greatly influence the pooled point estimates as compared with studies where the definition of AKI was restricted to dialysis requirement. For the outcome of dialysis requirement, studies with a higher incidence of AKI and studies with lower Jadad quality scores were associated with larger effects. For the outcome of death, studies restricted to elective setting and those with lower Jadad quality scores were associated with a larger effect favoring off-pump CABG. All but three studies that reported preoperative serum creatinine had no outcome events, precluding a meaningful subgroup analysis based on this variable.
Summary OR estimates were not affected when the largest trial (33) was excluded from the analysis for AKI (OR 0.60; 95% CI 0.43, 0.84 versus OR 0.56; 95% CI 0.39, 0.81) and dialysis requirement (OR 0.67; 95% CI 0.40, 1.12 versus OR 0.58; 95% CI 0.31, 1.08). Notably, however, when a relatively small trial with the highest reported incidence of AKI was † Study omitted from meta-analyses because there were no events in both groups: The displayed estimate and CI were calculated by adjusting the numbers of events and nonevents.
excluded from the analysis for the outcome of AKI (52) the statistical significance was lost (OR 0.73; 95% CI 0.50, 1.07), although the point estimate remained similar to the overall analysis. This relatively small study had a 62% incidence of AKI in the on-pump CABG group. Although this study's large effects size might seem improbable as compared with the ones observed in larger studies such as the Randomized On/Off Bypass (ROOBY) trial, this might be due in part to a very sensitive definition of AKI used by the authors and to the inclusion criteria that were restricted to patients with pre-existing renal dysfunction. This trial also had the third highest rate of dialysis requirement in the on-pump CABG group (5%) among all studies.
Funnel plots were slightly asymmetric on visual inspection for all three measured outcomes, possibly suggesting unpublished studies favoring on-pump CABG (data not shown).
Discussion
The present meta-analysis suggests that off-pump CABG performed in a relatively heterogeneous patient population with coronary artery disease is associated with a reduction in the incidence of AKI but has no effect on dialysis requirement or all-cause mortality. Meta-analyses of the published literature are commonly used to assess treatment effect by allowing similar trials to be combined quantitatively, thereby increasing the precision of treatment effect estimates. In the past decade, six meta-analyses were published, five comparing the effect of off-pump versus on-pump CABG on major adverse outcomes including development of AKI (19 -21,23,24) , and one was specifically designed to evaluate kidney end points (22) . A summary of these six meta-analyses is provided in Table 3 . In brief, these authors used a small number of RCTs and included observational studies in their meta-analysis.
The recently published large multicenter ROOBY trial assigned 2203 patients scheduled for urgent or elective CABG to on-pump or off-pump procedures (33) . This study alone had more patients than any of the five previously published metaanalyses when considering only RCTs. The ROOBY trial showed no statistically significant benefit of off-pump CABG on kidney end points; moreover, at 1 year of follow-up, the off-pump group had worse composite outcomes of all-cause mortality, repeat revascularization, or nonfatal myocardial infarction than did the on-pump group (33) .
Our updated meta-analysis of RCTs showed a statistically significant benefit of off-pump versus on-pump CABG with respect to AKI when a liberal definition was used (consisting of a mixture of biochemical parameters/urine output/dialysis requirement criteria), but no significant benefit with respect to dialysis requirement or mortality.
Our data synthesis has several strengths. The robust nature of our global findings is supported by a nonsignificant statistical heterogeneity test and by the fact that the lower OR for † Study omitted from meta-analyses because there were no events in both groups: The displayed estimate and CI were calculated by adjusting the numbers of events and nonevents.
AKI in the off-pump CABG group persisted in almost every subgroup analysis. Moreover, our results are in agreement with those observed in the largest trial published to date (33) .
However, there are several important limitations to consider. We were unable to identify unpublished reports, which might have biased our results toward the off-pump benefit. In fact, funnel plots showed visual asymmetry, which might denote publication bias but might also be secondary to other causes (54) . Another shortcoming is the use of different definitions of AKI with most trials defining AKI as the need for dialysis or a Kobayashi (2005) Vedin (2005) Straka (2004) Tatoulis (2006) van Dijk (2001) Shroyer ( The displayed estimate and CI were calculated by adjusting the numbers of events and nonevents. † Study omitted from meta-analyses because there were no events in both groups: The displayed estimate and CI were calculated by adjusting the numbers of events and nonevents. mixture of a biochemical/urine output parameter or dialysis requirement. We can only speculate as to whether the inclusion of less severe forms of AKI, or defining AKI purely on the basis of serum creatinine or urine output fluctuations, would have yielded different results. Also, the small sample size of most of the studies resulting in low to zero event rates is a major limitation of the evidence. We were also unable to perform a subgroup analysis by baseline kidney function because the studies included in this meta-analysis provided insufficient data on pre-existing kidney disease to perform such analysis. Finally, the lower odds of AKI observed in our analysis did not translate into lower odds of death. Ascertaining only death in trials that provided kidney outcomes (the primary objective of our meta-analysis) might have influenced the assessment of this secondary end point, although there is no obvious reason why relative mortality rates would differ in studies that reported AKI outcomes and those that did not.
Four ongoing large multicenter RCTs comparing the effect of off-pump versus on-pump CABG on clinical outcomes are expected to enroll a total of 7800 patients and to conclude within the next 5 years (55-58). However, only two of the four trials list AKI as a primary outcome as a single or composite end point (57, 58) .
In conclusion, in the present meta-analysis, off-pump CABG appears to reduce the risk of AKI compared with on-pump surgery. These findings are hampered by the variable AKI definitions used in individual trials, precluding definitive conclusions. A subgroup analysis restricted to dialysis requirement, a well accepted and very serious complication of cardiac surgery, was not influenced by the surgical technique. The selection of surgical candidates deemed at low risk for developing postoperative AKI might explain in part why the offpump CABG technique had no added protection in some studies. Therefore, a large multicenter RCT recruiting surgical Figure 5 . Subgroup analyses displaying the effect of off-pump versus on-pump CABG on the incidence of AKI, dialysis requirement, and mortality. Peto fixed-effect model estimate of OR. The P value refers to the difference among subgroups using the t test. *Where indicated, the subgroups represent trials with variables of interest that are above or below the median value.
candidates with preoperative high-risk of renal dysfunction (i.e., those with chronic kidney disease or resolving contrastinduced nephropathy) is warranted to validate the potential advantage of off-pump over on-pump CABG in this population. Such a trial should be primarily powered to ascertain AKI as a primary end point using a composite of major kidney end points such as the doubling of serum creatinine or dialysis requirement.
